The historical rank and industry rank for WAVE Life Sciences's FCF Margin % or its related term are showing as below:
WVE'
s FCF Margin % Range Over the Past 10 Years
Min: -9463.16 Med: -893.28 Max: -18.13
Current: -140.32
During the past 12 years, the highest FCF Margin % of WAVE Life Sciences was -18.13%. The lowest was -9463.16%. And the median was -893.28%.
WVE's FCF Margin % is ranked better than 50.34% of 1019
companies
in the Biotechnology industry
Industry Median: -144.89
vs WVE: -140.32
WAVE Life Sciences FCF Margin % Historical Data
The historical data trend for WAVE Life Sciences's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of WAVE Life Sciences's FCF Margin %
For the Biotechnology subindustry, WAVE Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WAVE Life Sciences's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, WAVE Life Sciences's FCF Margin % distribution charts can be found below:
* The bar in red indicates where WAVE Life Sciences's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAVE Life Sciences FCF Margin % Related Terms
Thank you for viewing the detailed overview of WAVE Life Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WVE has been successfully added to your 